US Pharmaceutical Contract Manufacturing Market
US Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Service (API Manufacturing, FDF Manufacturing, Fill?Finish & Packaging Services, and Other), By Product (Small Molecules, and Biologic Products), By End-User (Batch Manufacturing, Continuous Manufacturing, Single?Use Technology Lines, Advanced Bioprocess Systems), Forecast Period 2026-2035
Industry Overview
US pharmaceutical contract manufacturing market was valued at $52.5 billion in 2025 and is projected to reach $115.7 billion by 2035, growing at a CAGR of 6.4% during the forecast period (2026–2035). The expansion of the global pharmaceutical contract manufacturing market is being supported by rising demand for outsourced production capabilities across both established and emerging healthcare economies. Increasing complexity in drug development, particularly in biologics and specialty medicines, is encouraging pharmaceutical companies to rely more on external manufacturing partners. Growth in chronic disease prevalence and the need for faster commercialization of therapies are further contributing to higher outsourcing activity. In addition, advancements in manufacturing technologies and regulatory support for high-quality production are strengthening industry participation. Capacity additions across key regions are also improving supply reliability and production efficiency. Overall, these factors are collectively supporting steady growth in the global contract manufacturing landscape.
Market Dynamics
Strong Capital Inflows Driving Manufacturing Scale-Up
The US pharmaceutical contract manufacturing market is witnessing strong capital inflows from both global pharma companies and domestic investors. Large-scale funding is being directed toward expanding production capacity to meet rising global demand for medicines. Companies are prioritizing infrastructure development to reduce supply chain dependency and enhance production resilience. This investment momentum is also encouraging faster adoption of advanced manufacturing infrastructure. As a result, the country is strengthening its position as a key global production base for pharmaceuticals. Additionally, investments are increasingly focused on long-term capacity building rather than short-term expansion. This is improving overall supply stability across critical therapeutic segments.
Rising Focus on High-Value and Complex Drug Production
There is a growing shift toward manufacturing of complex and high-value therapeutics that require specialized expertise and advanced facilities. Pharmaceutical companies are increasingly outsourcing production of innovative therapies to contract manufacturers with strong technical capabilities. This trend is supported by increasing demand for precision medicines and advanced treatment options across global healthcare systems. CDMOs are responding by expanding technical capabilities and improving process efficiency. This is contributing to higher-value output across the U.S. manufacturing ecosystem. In parallel, rising regulatory expectations are pushing manufacturers to enhance quality assurance frameworks. This is further elevating the role of specialized CDMOs in the market.
Market Segmentation
- Based on the product type, the market is segmented API manufacturing, FDF manufacturing, fill?finish & packaging services, and other.
- Based on the application, the market is segmented into small molecules, and biologic products.
- Based on the end-user, the market is segmented into batch manufacturing, continuous manufacturing, single?use technology lines, advanced bioprocess systems.
Biologic Products Leading Expansion Driver
Biologic products represent the largest and fastest growing area within the U.S. contract manufacturing landscape due to increasing demand for advanced therapies. Growth is strongly supported by rising adoption of monoclonal antibodies, vaccines, and cell-based treatments. Major players such as Thermo Fisher Scientific, Lonza, and FUJIFILM Diosynth are expanding biologics capacity through large-scale facility investments. Increasing complexity in drug development has pushed pharmaceutical firms to rely heavily on specialized biologics manufacturers. Continuous investments in biomanufacturing infrastructure are strengthening production scalability. Recent trends also show a shift toward flexible and modular facilities to reduce production timelines. Overall, biologics remain central to long-term market expansion in the U.S. CDMO industry.
Fill-Finish & Packaging Services – Rapidly Scaling Segment
Fill-finish and packaging services are emerging as a critical and fast-growing segment due to increasing demand for injectable and sterile drug formats. Growth is driven by higher outsourcing from pharmaceutical companies seeking efficiency and compliance with strict regulatory requirements. Leading CDMOs like Catalent, Baxter BioPharma Solutions, and PCI Pharma Services are investing in advanced sterile filling lines. Rising demand for pre-filled syringes and biologic drug delivery systems is further accelerating expansion. Companies are also adopting automation and isolator-based technologies to enhance safety and productivity. Recent industry movement indicates growing preference for integrated packaging solutions within CDMO offerings. This segment continues to gain momentum as global drug pipelines become more complex and time-sensitive.
Market Players Outlook
The major companies operating in the US pharmaceutical contract manufacturing market include Thermo Fisher Scientific Inc. (Patheon Pharma Services), Lonza Group AG, Catalent, Inc., Pfizer CentreOne, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In March 2026, Forma Life Sciences launched a US based contract development and manufacturing organization (CDMO) focused on oral solid dosage drugs, operating from two GMP facilities in Irvine, California. The company provides end-to-end services including formulation development, clinical manufacturing (Phase I–III), scale-up, and commercial production of tablets and capsules, with an annual capacity of over two billion units.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the US pharmaceutical contract manufacturing market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- US Pharmaceutical Contract Manufacturing Market Sales Analysis – Service | Product | Manufacturing Process | ($ Million)
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key US Pharmaceutical Contract Manufacturing Industry Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For US Pharmaceutical Contract Manufacturing Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For US Pharmaceutical Contract Manufacturing Market: Impact Analysis
- Market Opportunities
- Opportunities For US Pharmaceutical Contract Manufacturing Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – US Pharmaceutical Contract Manufacturing Market Revenue and Share
- Pharmaceutical Contract Manufacturing Product Comparison Analysis
- Key Company Analysis
- Catalent, Inc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Lonza Group AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Pfizer CentreOne
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc. (Patheon Pharma Services)
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Catalent, Inc
- Key Company Analysis
- US Pharmaceutical Contract Manufacturing Market Sales Analysis by Service ($ Million)
- API Manufacturing
- FDF Manufacturing
- Fill?Finish & Packaging Services
- Other
- US Pharmaceutical Contract Manufacturing Market Sales Analysis by Product ($ Million)
- Small Molecules
- Biologic Products
- US Pharmaceutical Contract Manufacturing Market Sales Analysis by End-User ($ Million)
- Batch Manufacturing
- Continuous Manufacturing
- Single?Use Technology Lines
- Advanced Bioprocess Systems
- Company Profiles
- AbbVie Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Avid Bioservices, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ajinomoto Bio-Pharma Services
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Alcami Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Baxter International Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cambrex Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Catalent, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Corden Pharma Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Curia Global, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Emergent BioSolutions Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Grand River Aseptic Manufacturing, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- OptraScan Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jubilant HollisterStier LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- KBI Biopharma, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lonza Group AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PCI Pharma Services
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer CentreOne (Pfizer Inc.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siegfried USA, LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc. (Patheon Pharma Services)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AbbVie Inc.
1. US Pharmaceutical Contract Manufacturing Market Research and Analysis by Service, 2025–2035 ($ Million)
2. US Pharmaceutical API Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
3. US Pharmaceutical FDF Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
4. US Pharmaceutical Fill-Finish & Packaging Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
5. US Pharmaceutical Other Contract Manufacturing Service Market Research and Analysis by Region, 2025–2035 ($ Million)
6. US Pharmaceutical Contract Manufacturing Market Research and Analysis by Product, 2025–2035 ($ Million)
7. US Small Molecules Pharmaceutical Drug Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
8. US Biologic Pharmaceutical Drug Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
9. US Pharmaceutical Contract Manufacturing Market Research and Analysis by Manufacturing Process, 2025–2035 ($ Million)
10. US Pharmaceutical Batch Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
11. US Pharmaceutical Continuous Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
12. US Pharmaceutical Single-Use Technology Lines Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
13. US Pharmaceutical Advanced Bioprocess Systems Contract Manufacturing Market Research and Analysis by Region, 2025–2035 ($ Million)
1. US Pharmaceutical Contract Manufacturing Market Share by Service, 2025 Vs 2035 (%)
2. US Pharmaceutical API Contract Manufacturing Scanner Market Share by Region, 2025 Vs 2035 (%)
3. US Pharmaceutical FDF Contract Manufacturing Software Market Share by Region, 2025 Vs 2035 (%)
4. US Pharmaceutical Fill-Finish & Packaging Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
5. US Pharmaceutical Other Contract Manufacturing Service Market Share by Region, 2025 Vs 2035 (%)
6. US Pharmaceutical Contract Manufacturing Market Share by Product, 2025 Vs 2035 (%)
7. US Pharmaceutical Small Molecules Drug Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
8. US Pharmaceutical Biologic Products Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
9. US Pharmaceutical Contract Manufacturing Market Share by End-User, 2025 Vs 2035 (%)
10. US Pharmaceutical Batch Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
11. US Pharmaceutical Continuous Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
12. US Pharmaceutical Single-Use Technology Lines Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
13. US Pharmaceutical Advanced Bioprocess Systems Contract Manufacturing Market Share by Region, 2025 Vs 2035 (%)
- Printable version
- No restriction to number of users within the company
